ArticleBMC biotechnology2026
Establishment and in vitro validation of a sheep-specific, low-cost TLR7/8 agonist R848-mediated X/Y sperm separation system.
Article in BMC biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sex control is crucial for maximizing the economic benefits of sheep husbandry: male lambs increase farm income by 30-40% due to superior growth and feed efficiency, while female lambs are essential for fine-wool production and population expansion. However, the only commercialized method (flow cytometry) has critical sheep-specific limitations, including 25-30% flow channel blockage, sperm DNA oxidative damage, and prohibitive cost for large-scale breeding. TLR7/8 agonist R848 has been validated for sperm separation in mice, cattle and goats, but no sheep-specific optimized system has been established due to unique biological characteristics of ovine sperm. In this study, we systematically optimized key parameters of R848-mediated sheep sperm separation, comprehensively evaluated its effects on sperm biological characteristics, and verified separation efficiency at the embryo level via IVF combined with nested PCR sex identification. The optimal R848 concentration was 1 µM: the upper layer was enriched with 90.30% ± 5.21% TLR8-negative Y sperm (validated by 80.20% ± 3.70% male embryos), and the lower layer was enriched with 80.50% ± 4.96% TLR8-positive X sperm (validated by 87.56% ± 9.51% female embryos). R848 specifically inhibited X-sperm motility by reducing ATP production (24.82% decrease, P = 0.006) and mitochondrial membrane potential (29.75% decrease, P = 0.023), without damaging acrosome or plasma membrane integrity. The optimal supporting conditions were determined as 1000 µL elution twice, Y-sperm storage at 17 °C for up to 120 h with stable in vitro performance, and X-sperm use within 24 h after sorting. This study provides a low-cost, sheep-specific sperm separation system with comprehensive in vitro validation, which has significant potential for application in precision sheep breeding after further in vivo validation.
Indexed as
Identifiers
42919281What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.